Ishita Drugs & Industries share news and announcements
BSE: 524400Pharmaceuticals & BiotechnologySmall Cap
Last close ₹70.01down ₹2.74 (3.77%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹72.75.
52-week range of traded prices to 23 Oct 2026
₹66.00Low, 13 Jan 2026₹90.85High, 29 Dec 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹21 Cr4,064th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 8 Aug 2026
- 29.6
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 30 May 2026
- 1.8
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 8 Aug 2026
- 6.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 8 Aug 2026
- 5.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 30 May 2026
- 0.01
- Volume, BSEVolume. Shares traded on the last trading day.
- 211
Ishita Drugs & Industries share news and announcements
525 announcements, routine notices left out, newest first. Page 11 of 11.
Mar 2012
Feb 2012
18 Feb · Limited Review for Dec 31, 2011
Jan 2012
Oct 2011
Sep 2011
3 Sep · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from September 23, 2011 to September 30, 2011 (both ....
Aug 2011
May 2011
Mar 2011
11 Mar · Board Meeting Cancelled
Board Meeting of Directors of the Company was not held scheduled on March 07, 2011 due to unavoidable circumstance & will be postponed. ....5 Mar · Board Meeting on Mar 07, 2011
Meeting of the Board of Directors of the Company will be held on March 07, 2011, inter alia, to consider the following business : ....
Feb 2011
Nov 2010
Oct 2010
Aug 2010
25 Aug · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from September 25, 2010 to September 30, 2010 (both ....
Jul 2010
May 2010
Mar 2010
8 Mar · Meeting
Members at the Extra Ordinary General Meeting (EGM) of the Company held on March 04, 2010, have accorded to the commencement of new ....
Feb 2010
Jan 2010
28 Jan · Board meeting
Board of Directors of the Company at its meeting held on January 23, 2010, inter-alia, has approved the following : 1. Commencement ....14 Jan · Ishita Drugs - Board Meeting on Jan 23, 2010
Meeting of the Board of Directors of the Company will be held on January 23, 2010, inter alia, to consider the following business: ....